logo
IsoEnergy Commences Athabasca Basin Summer 2025 Exploration Program

IsoEnergy Commences Athabasca Basin Summer 2025 Exploration Program

Cision Canadaa day ago

TORONTO, June 12, 2025 /CNW/ - IsoEnergy Ltd. ("IsoEnergy" or the "Company") (NYSE: ISOU) (TSX: ISO) is pleased to announce the commencement of its summer exploration program across its eastern Athabasca Basin uranium properties. The program is expected to encompass a total of 24 diamond drill holes for 11,000 metres of drilling on the Larocque East and Hawk projects, following up on encouraging results from the winter 2025 program at Larocque East and winter 2024 program at Hawk. Geochemical results from the winter program at Larocque East remain pending and are planned to be released once available.
Highlights
Larocque East Project (Figure 1)
A total of 20 diamond drill holes totaling 7,600 metres are planned to follow-up up on encouraging results from the winter 2025 program, targeting both resource expansion and regional discovery.
Hurricane Resource Expansion – Drilling will continue to test the potential of the Hurricane Main and South trends, focusing on step-outs near the existing deposit (the " Deposit") (Figure 1).
Greenfield Targets Along the Larocque Trend – Drilling will test Target Area D, 2.8 kilometres east of the Deposit, where the Company intersected the strongest radioactivity to date outside of the main mineral resource area. Additional drilling is planned at Target E, where summer 2024 drilling intersected elevated radioactivity and hydrothermal alteration near the unconformity and, Target F. Target K, located approximately 800 metres north of the main Hurricane conductor, identified in a new geophysical interpretation will also be drill tested along the 2,500 metre trend.
Hawk Project
4 diamond drill holes totaling 3,400 metres are planned to target coincident electromagnetic conductors and Ambient Noise Tomography (" ANT") velocity anomalies along a sparsely drill-tested, 12-kilometre-long prospective corridor. Previous drilling intersected structural disruption, alteration, and elevated uranium geochemistry and radiometric responses, features consistent with a setting conducive to unconformity-style uranium mineralization (Figure 3).
Saskatchewan Forest Fire Situation
Mobilization for the drill program has been impacted due to severe forest fire activity in Northern Saskatchewan. The program is initially operating with one drill based out of Points North. Once conditions improve, specifically when the fires near La Ronge and along Highway 102 subside and safe transport routes are restored, the Larocque East camp is expected to be opened, and a second drill is planned to be deployed to accelerate the program.
Advancing Exploration Pipeline Across the Eastern Athabasca Basin
Additional work is planned this summer to advance a pipeline of exploration targets across the Company's earlier-stage projects. This includes a recently completed helicopter-borne MobileMT survey at the East Rim project, acquisition and processing of satellite hyperspectral data for the Bulyea River project, and potential prospecting, sampling, and mapping at the Bulyea River, East Rim and Evergreen projects (Figure 4).
Dan Brisbin, Vice President Exploration, commented, "Our summer 2024 and winter 2025 drilling returned encouraging results at both Hurricane and along the Larocque trend, with strong radioactivity having been intersected. As we await geochemistry results for recent drilling, we are excited to pick up where we left off and continue advancing the potential for resource expansion along the main and south trends and additional discoveries along the 6-kilometre segment of the Hurricane trend to the east, particularly in target areas D and E. We are also eager to test, for the first time, the 2,500-metre trend located 800 metres north of the main conductor, an area that shares key geophysical characteristics with the Deposit. Lastly, we look forward to returning to the relatively underexplored Hawk project, where planned ground electromagnetic (" EM") and ANT surveys will guide drilling later this summer."
Resource Expansion Drilling at Hurricane
Following the success of the 2025 winter drill program (see news release dated April 23, 2025), exploration drilling has been proposed to further test several target areas (Figure 2).
The Hurricane Main trend, where winter drill holes LE25-194 and 198 intersected strong radioactivity. LE25-194, located 80 metres east of Hurricane, returned an average RS-125 spectrometer (" RS-125") reading on core of 3,100 counts per second (" cps") over 0.5 metres with a corresponding downhole probe maximum reading of 30,829 cps. LE25-198 intersected up to 625 cps on core and 26,503 cps downhole probe 180 metres east of Hurricane.
The Hurricane South trend, where winter drill holes LE25-207 and LE25-210 intersected strong radioactivity. Hole LE25-207, located 240 m east of Hurricane, returned an average RS-125 reading on over 0.5 metres on core of 8,800 cps and a corresponding downhole probe maximum reading of 30,096 cps, while LE25-210, drilled 480 metres east of Hurricane, intersected up to 3,700 cps averaged over 0.5 m on core and a corresponding downhole probe maximum reading of 20,280 cps.
Regional Targets on the Larocque Trend
Target Area D, 2.8 kilometres east of Hurricane, where winter drill hole LE25-202 intersected an average RS-125 reading on over 0.5 metres on core of 6,200 cps and up to 28,782 cps downhole probe within that interval – the highest radioactivity intersected on the project to date outside of the immediate Hurricane area. The LE25-202 intersection is on the western margin Target Area D at edge of an ANT seismic velocity anomaly where a new geophysical model generated earlier this year by Computational Geosciences Inc. and Convolutions Geoscience shows a potential splay in the Hurricane trend EM conductor package.
Target Area E is centred on a 1 kilometre by 2 kilometre ANT anomaly located 8 kilometre east of Hurricane at the eastern edge of the property where the 2025 conductivity model suggests an east-closing fold of the Hurricane host graphitic-pyritic pelite basement gneisses have been breached by east-northeast striking faults. Drill hole LE24-192, drilled in 2024, intersected 2.0 metres at 495 ppm U-p straddling the unconformity including 0.5 metres at 1,110 ppm U-p immediately below the unconformity. Drill hole LE24-180 returned 462 ppm U-p over 0.5 m. Unconformity depth in that hole was only 175 metres compared to 325 metres at the Hurricane deposit.
Target Area F, located in the northeast, is centered on the conductor corridor and aligns with roughly coincident resistivity and ANT velocity anomalies. Disruption of these geophysical patterns at the east end of Target Area F is inferred to reflect prospective structural complexity.
The new geophysical model generated earlier this year by Computational Geosciences Inc. and Convolutions Geoscience from joint inversion of historic EM and resistivity survey data highlighted a previously unexplored 2,500 metres long conductive trend 800 metres north of the main Hurricane conductor trend. This is interpreted as the eastern extension of the Hurricane conductor trend northern splay that originates near drill hole LE25-202. This target, referred to herein as Target Area K, exhibits two geophysical features like those at Hurricane: a flexure from a northeast trend to and east trend, and a conductivity decrease on the southwest end potentially due to the effects of alteration on the conductive host rocks.
The drilling program will be results driven, with drilling being reallocated among these target areas in response to mineralized intercepts. Drilling planned to begin at the Hawk project in August may also be reallocated to the Larocque East project if results warrant.
Hawk Project
Winter 2024 drill holes at the Hawk project intersected structure, alteration, and broad zones of elevated radioactivity typical of unconformity-related uranium deposits (see news release dated April 25, 2024). These holes were drilled to test EM conductors along a regional high conductivity trend mapped by Z-Axis Tipper Electromagnetic (" ZTEM") surveys and within a prominent ANT seismic velocity low interpreted to be due to structural disruption and alteration. The holes were drilled along trend to the north of 2023 drill holes HK23-03 and HK23-05A (Figure 3) that intersected structural disruption, desilicification, clay alteration, and "grey" zone sulphide mineralization with anomalous radioactivity and U-p geochemistry at the unconformity. Drill hole HK23-05A returned 168 ppm U-p over 2.0 metres in the basal sandstone including 511 ppm U-p over 0.5 metres immediately above the unconformity. HK23-08, which intersected the unconformity about 90 metres to the east, intersected 27 ppm U-p over 5.0 metres in the basal sandstone, including 99 ppm U-p over 0.5 m.
Exploration work planned for summer 2025 includes:
Stepwise moving loop EM surveying to more accurately locate conductors than the existing fixed loop EM surveys do. It is anticipated that this will improve drill hole targeting.
ANT surveys over the northern portion of the project to test for the extension of the existing ANT velocity anomaly along the conductivity corridor in an area where there is 35 metres of unconformity elevation change between 2023 drill holes HK23-01 and HK23-02.
Drill up to 3,400 metres in four holes to test targets along the Hawk conductivity corridor that will be finalized upon completion of the ground geophysical surveys.
Developing Drill Targets on Additional Highly Ranked Projects
Additional work is being planned for the summer of 2025 to develop a pipeline of exploration targets on the Company's earlier stage projects. An airborne MobileMT conductivity and magnetic survey was recently completed over the East Rim project. Data processing and interpretation are in progress.
Acquisition of satellite hyperspectral survey data for the Bulyea River project is planned for June. This data will be used for remote mineral mapping to help guide initial geological mapping, prospecting and sampling planned for late summer to follow up on historic highly anomalous uranium lake sediment geochemistry and radiometric anomalies detected by both historic and 2024 surveys completed for IsoEnergy by RAMP Geological Services Inc.
Qualified Person Statement
The scientific and technical information contained in this news release was reviewed and approved by Dr. Dan Brisbin, P.Geo., IsoEnergy's Vice President, Exploration, who is a "Qualified Person" (as defined in NI 43-101 – Standards of Disclosure for Mineral Projects). See the press releases referred to above for additional information, including data verification and quality assurance/quality control procedures, as well as the complete exploration results from the previous programs disclosed herein.
For additional information regarding the Company's Larocque East Project, including the current mineral resource estimate for IsoEnergy's Hurricane Deposit, please see the technical report entitled "Technical Report on the Larocque East Project, Northern Saskatchewan, Canada" dated August 4, 2022, available on the Company's profile at www.sedarplus.ca
About IsoEnergy Ltd.
IsoEnergy (NYSE American: ISOU andTSX: ISO) is a leading, globally diversified uranium company with substantial current and historical mineral resources in top uranium mining jurisdictions of Canada, the U.S. and Australia at varying stages of development, providing near-, medium- and long-term leverage to rising uranium prices. IsoEnergy is currently advancing its Larocque East project in Canada's Athabasca basin, which is home to the Hurricane deposit, boasting the world's highest-grade indicated uranium mineral resource.
IsoEnergy also holds a portfolio of permitted past-producing, conventional uranium and vanadium mines in Utah with a toll milling arrangement in place with Energy Fuels. These mines are currently on standby, ready for rapid restart as market conditions permit, positioning IsoEnergy as a near-term uranium producer.
www.isoenergy.ca
Cautionary Statement Regarding Forward-Looking Information
This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation and "forward-looking statements" within the meaning of U.S. securities laws (collectively, "forward-looking statements"). Generally, forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". These forward-looking statements may relate to the Company's properties, planned exploration activities for summer 2025 and the anticipated results thereof; and any other activities, events or developments that the Company expects or anticipates will or may occur in the future.
Forward-looking statements are necessarily based upon a number of assumptions that, while considered reasonable by management at the time, are inherently subject to business, market and economic risks, uncertainties and contingencies that may cause actual results, performance or achievements to be materially different from those expressed or implied by forward-looking statements. Such assumptions include, but are not limited to, assumptions that the results of planned exploration activities are as anticipated and will be reported when anticipated; the anticipated mineralization of IsoEnergy's projects being consistent with expectations; the price of uranium; the anticipated cost of planned exploration activities; that general business and economic conditions will not change in a materially adverse manner; that financing will be available if and when needed and on reasonable terms; and that third party contractors, equipment and supplies and governmental and other approvals required to conduct the Company's planned activities will be available on reasonable terms and in a timely manner. Although IsoEnergy has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.
Such statements represent the current views of IsoEnergy with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by IsoEnergy, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties. Risks and uncertainties include, but are not limited to the following: negative operating cash flow and dependence on third party financing; uncertainty of additional financing; no known mineral reserves; aboriginal title and consultation issues; reliance on key management and other personnel; actual results of technical work programs and technical and economic assessments being different than anticipated; changes in development and production plans based upon results; availability of third party contractors; availability of equipment and supplies; failure of equipment to operate as anticipated; accidents, effects of weather and other natural phenomena; other environmental risks; changes in laws and regulations; regulatory determinations and delays; stock market conditions generally; demand, supply and pricing for uranium; other risks associated with the mineral exploration industry; and general economic and political conditions in Canada, the United States and other jurisdictions where the Company conducts business. Other factors which could materially affect such forward-looking statements are described in the risk factors in IsoEnergy's most recent annual management's discussion and analysis and annual information form and IsoEnergy's other filings with securities regulators which are available under the Company's profile on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tamarack Valley Energy Announces Monthly Dividend Declaration and Extension of Credit Facility
Tamarack Valley Energy Announces Monthly Dividend Declaration and Extension of Credit Facility

Cision Canada

time27 minutes ago

  • Cision Canada

Tamarack Valley Energy Announces Monthly Dividend Declaration and Extension of Credit Facility

CALGARY, AB, June 13, 2025 /CNW/ - Tamarack Valley Energy Ltd. (" Tamarack" or the " Company") (TSX: TVE) is pleased to announce the declaration of its monthly dividend and extension of its Credit Facility. Dividend Declaration Tamarack's Board of Directors has declared a monthly cash dividend on its common shares of $0.01275 per share in accordance with the Company's dividend policy. The dividend will be payable on July 15, 2025, to shareholders of record at the close of business on June 30, 2025. This monthly cash dividend is designated as an "eligible dividend" for Canadian income tax purposes. Credit Facility extension Tamarack has access to a covenant-based $875MM revolving lending facility (the "Credit Facility") that was previously maturing on April 30, 2027. In June 2025, the Credit Facility was amended primarily to extend the maturity date of the facility by one year to April 30, 2028. As of June 13, 2025, Tamarack had access to over $400MM of undrawn credit under the three-year Credit Facility and an uncommitted accordion feature that provides the Company with the ability to access an incremental $125MM million of secured debt, subject to certain conditions, including approvals from the lending syndicate. About Tamarack Valley Energy Ltd. Tamarack is an oil and gas exploration, and production company committed to creating long-term value for its shareholders through sustainable free funds flow generation, financial stability and the return of capital. The Company has an extensive inventory of low-risk, oil development drilling locations focused primarily on Clearwater and Charlie Lake plays in Alberta while also pursuing EOR upside in these core areas. For more information, please visit the Company's website at Forward Looking Information This press release contains certain forward-looking information (collectively referred to herein as "forward- looking statements") within the meaning of applicable Canadian securities laws. Forward-looking statements are often, but not always, identified by the use of words such as "guidance", "outlook", "anticipate", "target", "plan", "continue", "intend", "consider", "estimate", "expect", "may", "will", "should", "could" or similar words suggesting future outcomes. More particularly, this press release contains forward- looking statements concerning: Tamarack's business strategy, objectives, strength and focus; the future declaration and payment of dividends and the timing and amount thereof; and available credit capacity under the Credit Facility. Future dividend payments and share buybacks, if any, and the level thereof, are uncertain, as the Company's return of capital framework and the funds available for such activities from time to time is dependent upon, among other things, free funds flow financial requirements for the Company's operations and the execution of its growth strategy, fluctuations in working capital and the timing and amount of capital expenditures, debt service requirements and other factors beyond the Company's control. Further, the ability of Tamarack to pay dividends and buyback shares will be subject to applicable laws (including the satisfaction of the solvency test contained in applicable corporate legislation) and contractual restrictions contained in the instruments governing its indebtedness, including its Credit Facility. The forward-looking statements contained in this document are based on certain key expectations and assumptions made by Tamarack, including those relating to: the business plan of Tamarack; the timing of and success of future drilling, development and completion activities; the geological characteristics of Tamarack's properties; the continued successful integration of acquired assets into Tamarack's operations; prevailing commodity prices, price volatility, price differentials and the actual prices received for the Company's products; the availability and performance of drilling rigs, facilities, pipelines and other oilfield services; the timing of past operations and activities in the planned areas of focus; the drilling, completion and tie-in of wells being completed as planned; the performance of new and existing wells; the application of existing drilling and fracturing techniques; prevailing weather and break-up conditions; royalty regimes and exchange rates; impact of inflation on costs; the application of regulatory and licensing requirements; the continued availability of capital and skilled personnel; the ability to maintain or grow the banking facilities; the accuracy of Tamarack's geological interpretation of its drilling and land opportunities, including the ability of seismic activity to enhance such interpretation; and Tamarack's ability to execute its plans and strategies. Although management considers these assumptions to be reasonable based on information currently available, undue reliance should not be placed on the forward-looking statements because Tamarack can give no assurances that they may prove to be correct. By their very nature, forward-looking statements are subject to certain risks and uncertainties (both general and specific) that could cause actual events or outcomes to differ materially from those anticipated or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: risks with respect to unplanned third party pipeline outages and risks relating to inclement and severe weather events and natural disasters, such as fire, drought and flooding, including in respect of safety, asset integrity and shutting-in production; the risk that future dividend payments are reduced, suspended or cancelled; unforeseen difficulties in integrating of recently acquired assets into Tamarack's operations; incorrect assessments of the value of benefits to be obtained from acquisitions and exploration and development programs; risks associated with the oil and gas industry in general (e.g. operational risks in development, exploration and production; and delays or changes in plans with respect to exploration or development projects or capital expenditures); commodity prices, including the impact of the actions of OPEC and OPEC+ members; changes in legislation, including but not limited to tariffs, tax laws, royalties and environmental regulations (including greenhouse gas emission reduction requirements and other decarbonization or social policies and including uncertainty with respect to the interpretation of omnibus Bill C-59 and the related amendments to the Competition Act (Canada)); the imposition or expansion of tariffs imposed by domestic and foreign governments or the imposition of other restrictive trade measures, retaliatory or countermeasures implemented by such governments, including the introduction of regulatory barriers to trade and the potential effect on the demand and/or market price for the Company's products and/or otherwise adversely affects the Company; the uncertainty of estimates and projections relating to production, cash generation, costs and expenses, including increased operating and capital costs due to inflationary pressures; health, safety, litigation and environmental risks; access to capital; and pandemics. In addition, ongoing military actions between Russia and Ukraine and the recent crisis in Israel and Gaza have the potential to threaten the supply of oil and gas from those regions. The long-term impacts of the actions between these nations remains uncertain. Due to the nature of the oil and natural gas industry, drilling plans and operational activities may be delayed or modified to respond to market conditions, results of past operations, regulatory approvals or availability of services causing results to be delayed. Please refer to the Company's annual information form for the year ended December 31, 2024, and management's discussion and analysis for the period ended March 31, 2025, for additional risk factors relating to Tamarack, which can be accessed either on Tamarack's website at or under the Company's profile on The forward-looking statements contained in this press release are made as of the date hereof and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, except as required by applicable law. The forward-looking statements contained herein are expressly qualified by this cautionary statement. SOURCE Tamarack Valley Energy Ltd.

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels
Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

Cision Canada

timean hour ago

  • Cision Canada

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

CLEVELAND, June 13, 2025 /CNW/ -- Primary Investigator, Bernardo Cortese MD, proudly announces the successful completion of patient enrollment in the TRANSFORM II randomized controlled trial (RCT). This pivotal study aims to evaluate the safety and efficacy of the MagicTouch Sirolimus-Coated Balloon (SCB) compared to an everolimus-eluting stent (EES) in treating de-novo coronary vessels. TRANSFORM II (Sirolimus-Coated Balloon Versus Drug-Eluting Stent in Native Coronary Vessels) is an investigator-driven trial sponsored by Fondazione Ricerca e Innovazione Cardiovascolare in Milano, Italy, and has now achieved its target enrollment of >1,820 patients. The final patient was enrolled on 6 th June 2025, marking a major milestone for the trial. Led by Study Chairman Prof. Bernardo Cortese (University Hospitals Harrington Heart & Vascular Institute, Cleveland, USA) and a distinguished steering committee, TRANSFORM II is one of the largest global randomized controlled trials evaluating drug-coated balloon and has enrolled patients from 52 centers across Europe, Asia and South America. Key features of the TRANSFORM II trial include: Comparative Arms: MagicTouch SCB vs. Everolimus-Eluting Stent (EES) Patient Population: 1,832 patients with de-novo lesions in coronary arteries (vessel diameter >2.0 mm to ≤3.5 mm; lesion length ≤50 mm) Primary Endpoint: Target Lesion Failure at 12 months, non-inferiority design Follow-Up: Patients will be monitored for up to 60 months (5 years) Sub-Study: Optical Coherence Tomography (OCT) imaging in 70 patients at 9 months to assess angiographic outcomes Prof. Bernardo Cortese, Study Chairman of TRANSFORM II, commented: "After 3 and a half years we were able to complete the enrollment in TRANSFORM II trial, a study that involved 52 centers across 3 continents, and this is amazing. The effort put by our Team in Fondazione RIC and each Investigator of the study led to a quite fast enrollment in such a big, ambitious study. Our goal is to advance the adoption of DCB in the coronary space, testing this sirolimus DCB with the most studied and used DES, in a daily patient population. Along with the guidance of the recently published DCB ARC guidelines, we are paving the route for the modern angioplasty era!". Coronary vessels of this size (which account for roughly 80% of patients undergoing percutaneous coronary interventions) present unique treatment challenges. Currently, interventional cardiologists must often choose a permanent implant namely a drug-eluting stent — effectively "caging" a small vessel — which may compromise long-term outcomes. The head-to-head comparison of MagicTouch SCB against a current standard of care (the EES family of drug-eluting stents) in TRANSFORM II is poised to provide critical evidence for an alternative approach. This trial has the potential to reshape treatment practices by establishing drug-coated balloons as the next viable option for patients with coronary artery disease. Drug-coated balloon technology has long been viewed as a promising solution for small, de-novo coronary lesions, and sirolimus is a viable alternative to the first generation of DCB eluting paclitaxel. Data from this large-scale RCT are expected to support a paradigm shift towards broader use of drug-coated balloons. Implanting a drug-eluting stent in a tiny artery is far from ideal for both patients and physicians, so a rigorous study validating the use of SCB was needed. TRANSFORM II is set to fulfill that need, with initial 12-month outcomes anticipated to shed light on the long-term benefits of avoiding permanent implants in coronary vessels. Dr. Manish Doshi, Founder & Managing Director of Concept Medical Group, commented: "The completion of patient enrollment in TRANSFORM II is a significant milestone in our mission to bring innovative drug-delivery technologies to the forefront of interventional cardiology. We are proud to scientifically support one of the largest global randomized trials evaluating sirolimus-coated balloon technology. This achievement reflects our commitment to clinical excellence, scientific rigor, and ultimately, better outcomes for patients around the world." About MagicTouch SCB The MagicTouch SCB, developed by Concept Medical Inc., utilizes proprietary Nanoluté technology to deliver sub-micron particles of sirolimus encapsulated in a biocompatible carrier, ensuring deep penetration into the vessel wall. The device has received CE Mark approval in Europe alongwith Breakthrough Device Designation & IDE Approval from the U.S. FDA for the treatment of small coronary vessels and in-stent restenosis with ongoing clinical trials. About Concept Medical Inc. Concept Medical Inc., headquartered in Tampa, Florida, has a global presence and is dedicated to enhancing patient care through cutting-edge research and development of drug-delivery technologies. Its proprietary platforms are designed to deliver pharmaceutical agents across vascular luminal surfaces with unparalleled precision. Concept Medical is the developer of the MagicTouch family of Sirolimus-Coated Balloons (SCB) – the world's first and most utilized SCB technology – well recognized for its versatility and efficacy in treating coronary and peripheral artery disease. The revolutionary MagicTouch and Abluminus product lines have been used to treat over a million patients globally, setting a new standard for vascular therapy.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store